References
- Bensky D, Gamble A. Chinese Herbal Medicine Materia Medica. Seattle: Eastland Press, 1992; 268–271.
- Alibeu JP, Jobert J. Aconite in Pediatrie 1990;45:465–466.
- Bae JK, Bae JY, Kwak JS, Kim SH,Suk GD. Experimental aconite neuroretinopathy in rabbit eye. J Korean Ophthalmol Soc 1988;29:337–345.
- Kim SD, Kim SH. Experimental aconitine optic neuropathy. J Korean
- Kim SH, Kim SD, Kim SY, Kwak JS. Myelo-optic neuropathy caused by aconitine in rabbit model. Jpn J Ophthalmol 1991;35:417–427.
- Joh HT, Kim SH. Aconitine induced
- Yoon KC, Kim SH. The changes of the visual evoked potential for aconitine induced visual pathway demyelination in rabbit model. J Korean Ophthalmol Soc 1992;33:622–626.
- Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon JC, Marshall LF, et al. treatment after acute spinal cord injury: I-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992; 77:324–327.
- Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405–1411.
- Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASIS 2. J Neurosurg 1993;79:500–507.
- Cazzato G, Mesiano T, Antonello R, Monti F, Carraro N, Tone P, Bosco A, Cargnelutti D. Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis. Eur Neurol 1995;35:193–198.
- Miller DH, Thompson AJ, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry 1992;55:450-453. Frequin ST, Barkhof F, Lamers ICJ.
- Hommes OR. The effects of high-dose methylprednisolone on gadolinium-enhanced MRI and cerebrospinal fluid measurements in multiple sclerosis. J Neuroimmunol 1992;40:265–272.
- Mauriello JA, DeLuca J, Krieger A, Schulder M, Frohman L. Management of traumatic optic neuropathy-a study of 23 patients. Br J Ophthalmol 1992; 76:349–352.
- Steinsapir KD, Goldberg RA. Traumatic optic neuropathy. Surv Ophthalmol 1994;38:487–518.
- Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol 1978;280: 273–301.
- Miller NR. Management of optic neuropathy. Arch Ophthalmol 1990; 108:1086–1087.
- Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol 1990;1 0: 665–669.
- Bartholdi D, Schwab ME. Methylpredisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 1995;672:177–186.
- Braughler JM, Hall ED. Current application of 'high-dose' steroid therapy for CNS injury. J Neurosurg 1985;62:806–810.